{
    "info": {
        "nct_id": "NCT03006172",
        "official_title": "A Phase I, Open-Label, Dose-Escalation Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0077 as a Single Agent in Patients With Locally Advanced or Metastatic PIK3CA-Mutant Solid Tumors and in Combination With Endocrine and Targeted Therapies in Patients With Locally Advanced or Metastatic PIK3CA-Mutant Breast Cancer",
        "inclusion_criteria": "* Evaluable or measurable disease per RECIST, Version 1.1 (measurable disease only for Arm D)\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\n* Life expectancy of greater than or equal to (>=) 12 weeks\n* Adequate hematologic and organ function, including blood counts, liver and kidney function\n\nStage I Arm A (Inavolisib):\n\n- Locally advanced, recurrent, or metastatic, PIK3CA mutant, incurable solid tumor malignancy, including breast cancer\n\nStages I and II, Arms B and C:\n\n- Postmenopausal female participants with locally advanced or metastatic PIK3CA-mutant HR+/HER2- breast cancer\n\nStage II, Arms D, E, or F:\n\n- Female participants with locally advanced or metastatic PIK3CA-mutant HR+/HER2- breast cancer\n\nStage II Arm D:\n\n- Prior treatment with CDK4/6 inhibitor\n\nStage II Arm G:\n\n* Female participants with locally advanced or metastatic PIK3CA-mutant HER2+ breast cancer\n* Left ventricular ejection fraction 50% or greater\n\nStages I and II:\n\n- All participants must provide tumor tissue from the primary or metastatic tumor site obtained from a prior or new biopsy or surgical procedure for detection of PIK3CA mutation by central laboratory test.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Metaplastic breast cancer\n* History of leptomeningeal disease\n* Type 1 or 2 diabetes requiring anti-hyperglycemic medication\n* Inability or unwillingness to swallow pills\n* Malabsorption syndrome or other condition that would interfere with enteral absorption\n* Known and untreated, or active central nervous system metastases\n* Uncontrolled pleural effusion or ascites\n* Any active infection that could impact patient safety or serious infection requiring intravenous antibiotics\n* History of other malignancy within 5 years, except for treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, or Stage I uterine cancer\n* History of or active ventricular dysrhythmias or congestive heart failure requiring medication or symptomatic coronary heart disease\n* Congenital long QT syndrome, prolonged QT interval, or family history of sudden unexplained death or long QT syndrome\n\nStage II Arms B, C, D, and E only:\n\n* Prior treatment with >1 chemotherapy regimen for metastatic disease\n* Prior treatment with PI3K inhibitor\n* History of significant toxicity related to mTOR inhibitor requiring treatment discontinuation\n\nStage II Arms B and E only:\n\n- Prior CDK4/6 inhibitor treatment\n\nStage II Arm G only:\n\n* Current uncontrolled hypertension or unstable angina\n* History of congestive heart failure, serious cardiac arrhythmia, or recent myocardial infarction\n* Prior ejection fraction decrease on trastuzumab\n* Prior cumulative doxorubicin greater than 360 mg/m2\n* Symptomatic active lung disease\n* History of significant toxicity related to trastuzumab and/or pertuzumab requiring discontinuation of treatment",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Evaluable or measurable disease per RECIST, Version 1.1 (measurable disease only for Arm D)",
            "criterions": [
                {
                    "exact_snippets": "Evaluable or measurable disease per RECIST, Version 1.1",
                    "criterion": "disease status",
                    "requirements": [
                        {
                            "requirement_type": "evaluation method",
                            "expected_value": "RECIST, Version 1.1"
                        },
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "evaluable",
                                "measurable"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "measurable disease only for Arm D",
                    "criterion": "disease status for Arm D",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "measurable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "0",
                                "1"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy of greater than or equal to (>=) 12 weeks",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy of greater than or equal to (>=) 12 weeks",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate hematologic and organ function, including blood counts, liver and kidney function",
            "criterions": [
                {
                    "exact_snippets": "Adequate hematologic ... blood counts",
                    "criterion": "hematologic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... organ function",
                    "criterion": "organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "blood counts",
                    "criterion": "blood counts",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "liver ... function",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "kidney function",
                    "criterion": "kidney function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stage I Arm A (Inavolisib):",
            "criterions": [
                {
                    "exact_snippets": "Stage I",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "I"
                        }
                    ]
                },
                {
                    "exact_snippets": "Arm A (Inavolisib)",
                    "criterion": "treatment arm",
                    "requirements": [
                        {
                            "requirement_type": "assignment",
                            "expected_value": "Arm A"
                        },
                        {
                            "requirement_type": "treatment",
                            "expected_value": "Inavolisib"
                        }
                    ]
                }
            ]
        },
        {
            "line": "- Locally advanced, recurrent, or metastatic, PIK3CA mutant, incurable solid tumor malignancy, including breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Locally advanced, recurrent, or metastatic",
                    "criterion": "tumor stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "locally advanced",
                                "recurrent",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "PIK3CA mutant",
                    "criterion": "PIK3CA mutation",
                    "requirements": [
                        {
                            "requirement_type": "mutation status",
                            "expected_value": "mutant"
                        }
                    ]
                },
                {
                    "exact_snippets": "incurable solid tumor malignancy",
                    "criterion": "tumor curability",
                    "requirements": [
                        {
                            "requirement_type": "curability",
                            "expected_value": "incurable"
                        }
                    ]
                },
                {
                    "exact_snippets": "solid tumor malignancy",
                    "criterion": "tumor type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": "solid tumor"
                        }
                    ]
                },
                {
                    "exact_snippets": "including breast cancer",
                    "criterion": "cancer type",
                    "requirements": [
                        {
                            "requirement_type": "specific type",
                            "expected_value": "breast cancer"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stages I and II, Arms B and C:",
            "criterions": [
                {
                    "exact_snippets": "Stages I and II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "I",
                                "II"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "Arms B and C",
                    "criterion": "trial arm",
                    "requirements": [
                        {
                            "requirement_type": "arm",
                            "expected_value": [
                                "B",
                                "C"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "- Postmenopausal female participants with locally advanced or metastatic PIK3CA-mutant HR+/HER2- breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Postmenopausal female participants",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "postmenopausal"
                        }
                    ]
                },
                {
                    "exact_snippets": "female participants",
                    "criterion": "gender",
                    "requirements": [
                        {
                            "requirement_type": "gender",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "locally advanced or metastatic",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "PIK3CA-mutant",
                    "criterion": "PIK3CA mutation",
                    "requirements": [
                        {
                            "requirement_type": "mutation status",
                            "expected_value": "mutant"
                        }
                    ]
                },
                {
                    "exact_snippets": "HR+/HER2- breast cancer",
                    "criterion": "breast cancer subtype",
                    "requirements": [
                        {
                            "requirement_type": "subtype",
                            "expected_value": "HR+/HER2-"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stage II, Arms D, E, or F:",
            "criterions": [
                {
                    "exact_snippets": "Stage II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "II"
                        }
                    ]
                },
                {
                    "exact_snippets": "Arms D, E, or F",
                    "criterion": "treatment arm",
                    "requirements": [
                        {
                            "requirement_type": "arm",
                            "expected_value": [
                                "D",
                                "E",
                                "F"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "- Female participants with locally advanced or metastatic PIK3CA-mutant HR+/HER2- breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Female participants",
                    "criterion": "gender",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "locally advanced or metastatic",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "PIK3CA-mutant",
                    "criterion": "PIK3CA mutation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "HR+/HER2- breast cancer",
                    "criterion": "breast cancer subtype",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "HR+/HER2-"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stage II Arm D:",
            "criterions": [
                {
                    "exact_snippets": "Stage II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "II"
                        }
                    ]
                },
                {
                    "exact_snippets": "Arm D",
                    "criterion": "treatment arm",
                    "requirements": [
                        {
                            "requirement_type": "assignment",
                            "expected_value": "D"
                        }
                    ]
                }
            ]
        },
        {
            "line": "- Prior treatment with CDK4/6 inhibitor",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with CDK4/6 inhibitor",
                    "criterion": "CDK4/6 inhibitor treatment",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Female participants with locally advanced or metastatic PIK3CA-mutant HER2+ breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Female participants",
                    "criterion": "gender",
                    "requirements": [
                        {
                            "requirement_type": "expected_value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "locally advanced or metastatic",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "expected_value",
                            "expected_value": [
                                "locally advanced",
                                "metastatic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "PIK3CA-mutant",
                    "criterion": "PIK3CA mutation status",
                    "requirements": [
                        {
                            "requirement_type": "mutation",
                            "expected_value": "mutant"
                        }
                    ]
                },
                {
                    "exact_snippets": "HER2+ breast cancer",
                    "criterion": "HER2 status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "positive"
                        }
                    ]
                },
                {
                    "exact_snippets": "HER2+ breast cancer",
                    "criterion": "cancer type",
                    "requirements": [
                        {
                            "requirement_type": "expected_value",
                            "expected_value": "breast cancer"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Left ventricular ejection fraction 50% or greater",
            "criterions": [
                {
                    "exact_snippets": "Left ventricular ejection fraction 50% or greater",
                    "criterion": "left ventricular ejection fraction",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stages I and II:",
            "criterions": [
                {
                    "exact_snippets": "Stages I and II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": [
                                "I",
                                "II"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "- All participants must provide tumor tissue from the primary or metastatic tumor site obtained from a prior or new biopsy or surgical procedure for detection of PIK3CA mutation by central laboratory test.",
            "criterions": [
                {
                    "exact_snippets": "tumor tissue from the primary or metastatic tumor site",
                    "criterion": "tumor tissue",
                    "requirements": [
                        {
                            "requirement_type": "source",
                            "expected_value": [
                                "primary tumor site",
                                "metastatic tumor site"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "detection of PIK3CA mutation",
                    "criterion": "PIK3CA mutation",
                    "requirements": [
                        {
                            "requirement_type": "detection",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "volunteer health status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "healthy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Metaplastic breast cancer",
            "criterions": [
                {
                    "exact_snippets": "Metaplastic breast cancer",
                    "criterion": "metaplastic breast cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of leptomeningeal disease",
            "criterions": [
                {
                    "exact_snippets": "History of leptomeningeal disease",
                    "criterion": "leptomeningeal disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Type 1 or 2 diabetes requiring anti-hyperglycemic medication",
            "criterions": [
                {
                    "exact_snippets": "Type 1 or 2 diabetes",
                    "criterion": "diabetes type",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "Type 1",
                                "Type 2"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring anti-hyperglycemic medication",
                    "criterion": "anti-hyperglycemic medication",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": "required"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Inability or unwillingness to swallow pills",
            "criterions": [
                {
                    "exact_snippets": "Inability ... to swallow pills",
                    "criterion": "ability to swallow pills",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unwillingness to swallow pills",
                    "criterion": "willingness to swallow pills",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Malabsorption syndrome or other condition that would interfere with enteral absorption",
            "criterions": [
                {
                    "exact_snippets": "Malabsorption syndrome",
                    "criterion": "malabsorption syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "other condition that would interfere with enteral absorption",
                    "criterion": "condition interfering with enteral absorption",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known and untreated, or active central nervous system metastases",
            "criterions": [
                {
                    "exact_snippets": "Known and untreated, or active central nervous system metastases",
                    "criterion": "central nervous system metastases",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": [
                                "known and untreated",
                                "active"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled pleural effusion or ascites",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled pleural effusion",
                    "criterion": "pleural effusion",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "Uncontrolled ... ascites",
                    "criterion": "ascites",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any active infection that could impact patient safety or serious infection requiring intravenous antibiotics",
            "criterions": [
                {
                    "exact_snippets": "Any active infection",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serious infection requiring intravenous antibiotics",
                    "criterion": "serious infection",
                    "requirements": [
                        {
                            "requirement_type": "treatment",
                            "expected_value": "intravenous antibiotics"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of other malignancy within 5 years, except for treated carcinoma in situ of the cervix, non-melanoma skin carcinoma, or Stage I uterine cancer",
            "criterions": [
                {
                    "exact_snippets": "History of other malignancy within 5 years",
                    "criterion": "history of other malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "except for treated carcinoma in situ of the cervix",
                    "criterion": "treated carcinoma in situ of the cervix",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "except for ... non-melanoma skin carcinoma",
                    "criterion": "non-melanoma skin carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "except for ... Stage I uterine cancer",
                    "criterion": "Stage I uterine cancer",
                    "requirements": [
                        {
                            "requirement_type": "exclusion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of or active ventricular dysrhythmias or congestive heart failure requiring medication or symptomatic coronary heart disease",
            "criterions": [
                {
                    "exact_snippets": "History of or active ventricular dysrhythmias",
                    "criterion": "ventricular dysrhythmias",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "congestive heart failure requiring medication",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "medication requirement",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic coronary heart disease",
                    "criterion": "coronary heart disease",
                    "requirements": [
                        {
                            "requirement_type": "symptoms",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Congenital long QT syndrome, prolonged QT interval, or family history of sudden unexplained death or long QT syndrome",
            "criterions": [
                {
                    "exact_snippets": "Congenital long QT syndrome",
                    "criterion": "congenital long QT syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "prolonged QT interval",
                    "criterion": "QT interval",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": "prolonged"
                        }
                    ]
                },
                {
                    "exact_snippets": "family history of sudden unexplained death",
                    "criterion": "family history of sudden unexplained death",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "family history of ... long QT syndrome",
                    "criterion": "family history of long QT syndrome",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stage II Arms B, C, D, and E only:",
            "criterions": [
                {
                    "exact_snippets": "Stage II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "II"
                        }
                    ]
                },
                {
                    "exact_snippets": "Arms B, C, D, and E only",
                    "criterion": "trial arm",
                    "requirements": [
                        {
                            "requirement_type": "inclusion",
                            "expected_value": [
                                "B",
                                "C",
                                "D",
                                "E"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment with >1 chemotherapy regimen for metastatic disease",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with >1 chemotherapy regimen for metastatic disease",
                    "criterion": "chemotherapy regimen for metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior treatment with PI3K inhibitor",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with PI3K inhibitor",
                    "criterion": "PI3K inhibitor treatment",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of significant toxicity related to mTOR inhibitor requiring treatment discontinuation",
            "criterions": [
                {
                    "exact_snippets": "History of significant toxicity related to mTOR inhibitor requiring treatment discontinuation",
                    "criterion": "toxicity related to mTOR inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        },
                        {
                            "requirement_type": "consequence",
                            "expected_value": "treatment discontinuation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stage II Arms B and E only:",
            "criterions": [
                {
                    "exact_snippets": "Stage II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "II"
                        }
                    ]
                },
                {
                    "exact_snippets": "Arms B and E only",
                    "criterion": "trial arm",
                    "requirements": [
                        {
                            "requirement_type": "inclusion",
                            "expected_value": [
                                "B",
                                "E"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "- Prior CDK4/6 inhibitor treatment",
            "criterions": [
                {
                    "exact_snippets": "Prior CDK4/6 inhibitor treatment",
                    "criterion": "CDK4/6 inhibitor treatment",
                    "requirements": [
                        {
                            "requirement_type": "prior treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Stage II Arm G only:",
            "criterions": [
                {
                    "exact_snippets": "Stage II",
                    "criterion": "cancer stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "II"
                        }
                    ]
                },
                {
                    "exact_snippets": "Arm G only",
                    "criterion": "treatment arm",
                    "requirements": [
                        {
                            "requirement_type": "specific arm",
                            "expected_value": "G"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current uncontrolled hypertension or unstable angina",
            "criterions": [
                {
                    "exact_snippets": "Current uncontrolled hypertension",
                    "criterion": "hypertension",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina",
                    "criterion": "angina",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": "unstable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of congestive heart failure, serious cardiac arrhythmia, or recent myocardial infarction",
            "criterions": [
                {
                    "exact_snippets": "History of congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serious cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "serious"
                        }
                    ]
                },
                {
                    "exact_snippets": "recent myocardial infarction",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": "recent"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior ejection fraction decrease on trastuzumab",
            "criterions": [
                {
                    "exact_snippets": "Prior ejection fraction decrease on trastuzumab",
                    "criterion": "ejection fraction",
                    "requirements": [
                        {
                            "requirement_type": "prior decrease",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "medication",
                            "expected_value": "trastuzumab"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior cumulative doxorubicin greater than 360 mg/m2",
            "criterions": [
                {
                    "exact_snippets": "Prior cumulative doxorubicin greater than 360 mg/m2",
                    "criterion": "cumulative doxorubicin",
                    "requirements": [
                        {
                            "requirement_type": "amount",
                            "expected_value": {
                                "operator": ">",
                                "value": 360,
                                "unit": "mg/m2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Symptomatic active lung disease",
            "criterions": [
                {
                    "exact_snippets": "Symptomatic active lung disease",
                    "criterion": "lung disease",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of significant toxicity related to trastuzumab and/or pertuzumab requiring discontinuation of treatment",
            "criterions": [
                {
                    "exact_snippets": "History of significant toxicity related to trastuzumab",
                    "criterion": "toxicity related to trastuzumab",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "History of significant toxicity related to ... pertuzumab",
                    "criterion": "toxicity related to pertuzumab",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "toxicity ... requiring discontinuation of treatment",
                    "criterion": "toxicity",
                    "requirements": [
                        {
                            "requirement_type": "consequence",
                            "expected_value": "requiring discontinuation of treatment"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Stage II Arm G:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}